1.	Antifungal Use in Oncohematological Neutropenic Patients Phase: Phase IV Type: Supportive care Status: Completed Age: 2 and over Sponsor: Other Protocol IDs: 2005-004973-55, ANTIVORIFUNGOL, NCT00386802
2.	Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A1501038, NCT00143312
3.	Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: Other Protocol IDs: EORTC-19961, PFIZER-150-307-000, NCT00003031
4.	Phase III Randomized Study of Voriconazole Compared to Liposomal Amphotericin B as Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia (Summary Last Modified 09/1999) Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: NCI-98-C-0063, PFIZER-150-603
5.	Phase III Study of Voriconazole in Patients With Invasive Fungal Infections (Summary Last Modified 01/2001) Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI Protocol IDs: NCI-99-C-0094B, NCI-99-C-0094
6.	Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A1501029, NCT00150345
7.	Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 2 to 12 Sponsor: NCI, NHLBI Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
8.	Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis Phase: Phase III Type: Supportive care Status: Completed Age: 16 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A8851009, NCT00531479
9.	Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2008-0443, NCT00904995
10.	Phase II Randomized Pilot Study of Voriconazole With or Without Interferon gamma in Patients With Invasive Aspergillosis or Other Filamentous Fungal Infections Phase: Phase II Type: Supportive care Status: Completed Age: 2 and over Sponsor: NCI Protocol IDs: NCI-03-C-0111, NCT00059878
11.	Phase II Pilot Study of Voriconazole for the Prevention of Systemic Fungal Infection in Pediatric Patients With Neutropenia After Chemotherapy Phase: Phase II Type: Supportive care Status: Completed Age: 2 to 11 Sponsor: NCI Protocol IDs: NCI-03-C-0218, NCT00066599
12.	Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2006-0536, NCT00418951
13.	Phase I Study of Voriconazole versus Fluconazole in Patients with Hematologic Malignancies, Hematologic Conditions, or Solid Tumors at Risk for Aspergillosis (Summary Last Modified 10/98) Phase: Phase I Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MCV-CCHR-9603-2H, PFIZER-95CK39-0673, NCI-G97-1325
14.	Phase I Study of Voriconazole in Children Who Require Treatment for the Prevention of Systemic Fungal Infection (Summary Last Modified 03/2001) Phase: Phase I Type: Supportive care Status: Completed Age: 2 to 12 Sponsor: NCI Protocol IDs: NCI-00-C-0150
15.	Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Phase: No phase specified Type: Supportive care Status: Closed Age: 12 and over Sponsor: NCI, Other Protocol IDs: CDR0000355116, UCLA-0307071, NCT00079222
16.	Blood and Marrow Transplant Clinical Research Network Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 2 and over Sponsor: NHLBI Protocol IDs: 139, NCT00023530
17.	An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Not specified Sponsor: Other Protocol IDs: PMH-VOR, NCT01321372